Epiq Capital Group, LLC Lucira Health, Inc. Transaction History

Epiq Capital Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.11 - $0.83 $1.43 Million - $10.8 Million	-13,011,695 Reduced 94.72%	725,675 $79,000
Q3 2022 Nov 09, 2022	BUY	$1.27 - $3.39 $123,827 - $330,531	97,502 Added 0.71%	13,737,370 $14.6 Million
Q2 2022 Aug 15, 2022	SELL	$1.44 - $3.94 $423,002 - $1.16 Million	-293,752 Reduced 2.11%	13,639,868 $25.4 Million
Q1 2022 May 13, 2022	SELL	$2.86 - $8.83 $179,121 - $553,022	-62,630 Reduced 0.45%	13,933,620 $49.7 Million
Q4 2021 Feb 09, 2022	BUY	$4.94 - $8.94 $988,330 - $1.79 Million	200,067 Added 1.45%	13,996,250 $121 Million
Q3 2021 Nov 12, 2021	BUY	$6.05 - $10.81 $3.04 Million - $5.43 Million	502,733 Added 3.78%	13,796,183 $105 Million
Q2 2021 Jul 30, 2021	BUY	$4.56 - $11.45 $272,984 - $685,454	59,865 Added 0.45%	13,293,450 $88.3 Million
Q1 2021 May 03, 2021	BUY	$11.65 - $37.0 $154 Million - $490 Million	13,233,585 New	13,233,585 $160 Million

Ticker LHDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,106,500
Market Cap $1.2M
Description
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a paten...

Get notified when there are updates to the investment portfolio of Epiq Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Epiq Capital Group, LLC with notifications on news.